How It Ticks

Behind the Pharma Curtain: Navigating Drug Trials and Cancer Research with Professor Dario Neri

Jun 24, 2024

Professor Dario Neri, co-founder of Philogen, shares insights on drug trials, cancer research, and the pharmaceutical industry. From conflicting medical information to drug approval challenges, he delves into the complexities of drug development. The conversation also covers the landscape of cancer treatment companies and the balance between collaboration and competition in the industry.

01:08:01

Creator website

Episode guests

Dario Neri

AI Summary

AI Chapters

Episode notes

Podcast summary created with Snipd AI

Quick takeaways

Academic journey shapes pharmaceutical CEOs, such as Professor Neri, emphasizing the importance of mentors and hard work.

Challenges in drug development include conflicting medical research data and navigating differing regulatory bodies globally.

Collaboration and evidence-based medicine remain crucial in advancing cancer treatment research, balancing shareholder pressures with scientific integrity.

Deep dives

Innovative Cancer Treatment

Professor Dario Neri, a pioneering figure in the pharmaceutical industry, discusses his journey into developing innovative cancer treatments at Philagen. With over 400 publications in scientific journals, his expertise lies in medicinal chemistry and biotechnology, aiming to revolutionize cancer treatment.

Intro

2min

Academic Journey and Mentorship in Science and Pharmaceutical Research

3min

Comparing Cultural and Academic Aspects of Universities

2min

Navigating the World of Scientific Publishing and Cancer Research Business

18min

Regulation, Compassionate Treatments, and Clinical Trials

14min

Challenges and Opportunities in Pharmaceutical Development

14min

Preventing Skin Cancer and Early Cancer Screenings

10min

Navigating Academia and Hiring Practices at Village

5min

In this episode of "How It Ticks," I sit down with Professor Dario Neri, the co-founder, CEO, and CSO of Philogen, to explore the multifaceted world of pharmaceutical research and development. Our conversation begins with Dario’s inspiring journey in academia, including what it was like working under Nobel Prize winners.

We then delve into the complexities of publishing medical research and discuss why, particularly in fields like COVID-19, there is so much conflicting information. Dario offers his insights on the pharmaceutical industry’s negative reputation and the challenges posed by varying regulatory bodies across different countries.

Next, we break down the different phases of drug trials, examining the types of participants involved and the rigorous processes required to bring a drug to market. Dario also shares his perspective on the pressure from shareholders to expedite drug approvals and how he navigates this as a CEO. Lastly, we discuss the landscape of cancer treatment companies and whether they are seen as competitors or allies in the fight against cancer.

Tune in to gain a comprehensive understanding of the journey from academic research to life-saving treatments and the critical issues facing the pharmaceutical industry today.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.

How It Ticks

Behind the Pharma Curtain: Navigating Drug Trials and Cancer Research with Professor Dario Neri

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

Deep dives

Innovative Cancer Treatment

Academic Background and Professional Journey

Challenges and Advancements in Drug Development

Regulation and Peer-Reviewed Publications

Future of Pharmaceutical Research

Remember Everything You Learn from Podcasts